Pacific Biosciences of California (PACB) 6.96 $PACB
Pacific Biosciences Is Being Eaten Alive By Illumina
Doug Van Cuyk - at Seeking Alpha - Thu Feb 12, 7:59AM CST
PACB: 6.96 (-0.06), ILMN: 198.54 (+1.81)
Nasdaq stocks posting largest percentage decreases
AP - Thu Feb 05, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
SPLS: 16.86 (-0.22), PPSI: 9.09 (-0.26), ADXS: 7.18 (+0.06), GEOS: 19.15 (+0.02), MTRX: 19.92 (+0.77), AIRT: 19.45 (+0.39), PACB: 6.96 (-0.06), ADEP: 6.93 (-0.30), PRQR: 18.32 (-0.86), DERM: 16.52 (-0.11), LAYN: 7.93 (+0.22), ACHN: 10.89 (-0.20), POWL: 33.41 (+0.39), PLNR: 6.63 (-0.07), MFNC: 11.61 (+0.36)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 11:44AM CST
CALX: 8.65 (-0.03), NES: 3.52 (+0.13), RVP: 5.14 (-0.42), RL: 135.20 (-0.60), SR: 1.25 (+0.08), MWA: 9.19 (+0.09), OHGI: 1.82 (-0.12), GENE: 8.04 (+1.90), CALI: 1.35 (+0.06), WPRT: 6.06 (+0.26), RSYS: 2.15 (+0.05), EGLT: 10.60 (+0.58), PACB: 6.96 (-0.06), ACHN: 10.89 (-0.20), BBSI: 39.78 (+0.84), AVEO: 0.84 (-0.06), CBLI: 3.24 (+0.05), ENG: 1.85 (-0.06), PLNR: 6.63 (-0.07)
Why Shares of Pacific Biosciences of California Inc. Tanked Today
George Budwell, The Motley Fool - Motley Fool - Wed Feb 04, 11:29AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Shares of Pacific Biosciences of California plunged...
PACB: 6.96 (-0.06), FMI: 48.88 (+0.17)
Pac Bio down after earnings report
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 11:14AM CST
PACB: 6.96 (-0.06)
Pacific Biosciences Of California (PACB) Weak On High Volume Today
at The Street - Wed Feb 04, 9:03AM CST
Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a weak on high relative volume candidate
PACB: 6.96 (-0.06)
Pacific Bio ups revenues 115% in FY2014
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 8:53AM CST
PACB: 6.96 (-0.06)
Pacific Biosciences Posts Q4 Loss as Expected, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 8:28AM CST
Pacific Biosciences of California Inc. (PACB) plunged 5.2% (43 cents) to $7.90 in after-hours trading on the heels of disappointing fourth-quarter results.
ABMD: 60.39 (+0.46), PACB: 6.96 (-0.06), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Pacific Biosciences' Q4 2014 net loss widens to USD19.0m
M2 - Wed Feb 04, 5:24AM CST
DNA sequencing company Pacific Biosciences of California (NasdaqGS
ACB) on Tuesday disclosed a net loss of USD19.0m for the Q4 2014.
PACB: 6.96 (-0.06)
Pacific Biosciences of California's (PACB) CEO Michael Hunkapiller on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 03, 9:04PM CST
PACB: 6.96 (-0.06)
Pacific Biosciences reports 4Q loss
Automated Insights - Tue Feb 03, 3:58PM CST
MENLO PARK, Calif. (AP) _ Pacific Biosciences of California Inc. (PACB) on Tuesday reported a loss of $19 million in its fourth quarter.
PACB: 6.96 (-0.06)
Pacific Biosciences of California (PACB) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Feb 03, 3:25PM CST
PACB: 6.96 (-0.06)
Pacific Biosciences Reports Fourth Quarter 2014 Financial Results
GlobeNewswire - Tue Feb 03, 3:18PM CST
Pacific Biosciences of California, Inc. (Nasdaq ACB) today reported an 85% increase in revenue to $16.9 million for the fourth quarter ended December 31, 2014, compared to $9.1 million for the fourth quarter of 2013.
PACB: 6.96 (-0.06)
Pacific Biosciences of California EPS in-line, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 3:03PM CST
PACB: 6.96 (-0.06)
Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 4:35PM CST
CALX: 8.65 (-0.03), CHRW: 72.58 (+0.75), WYNN: 159.34 (+4.62), SPA: 22.31 (-0.02), MANH: 51.61 (+0.89), OCLR: 1.55 (+0.09), RSYS: 2.15 (+0.05), NSR: 24.61 (+0.10), CENT: 9.00 (-0.08), CMG: 674.89 (+4.60), AJG: 47.50 (+0.27), IACI: 64.60 (+0.96), VASC: 26.44 (+0.79), SLGN: 56.85 (-0.08), UNM: 34.76 (+0.51), ATW: 33.75 (+0.63), ENTR: 2.92 (unch), AEC: 23.85 (-0.32), AXS: 51.86 (+0.02), MYGN: 34.03 (+0.40), LSCC: 6.10 (+0.02), RNR: 103.80 (-0.64), CBL: 20.52 (-0.14), ATO: 52.52 (-0.65), EW: 134.23 (+1.89), EXP: 81.57 (+2.41), DIS: 104.17 (+0.59), MWA: 9.19 (+0.09), QNST: 6.15 (+0.07), TTWO: 28.40 (+0.96), ULTI: 163.76 (+1.60), PACB: 6.96 (-0.06), FISV: 78.70 (+0.25), GILD: 101.90 (+1.10), JKHY: 65.78 (+0.52), RNG: 16.04 (unch), WNC: 14.01 (+0.38), OMCL: 35.29 (+0.03), AFL: 62.13 (+0.33), HCSG: 33.23 (-0.13), WRB: 50.27 (+0.08), PLNR: 6.63 (-0.07), EQR: 78.75 (-1.11)
Will Pacific Biosciences (PACB) Surprise on Earnings in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 3:40PM CST
Pacific Biosciences of California, Inc. (PACB) has an earnings ESP of 0.00% and is scheduled to report fourth-quarter 2014 results on Feb 3, 2015 after the market closes.
ACT: 285.37 (+3.71), PACB: 6.96 (-0.06), ARIA: 7.35 (+0.45), REGN: 402.40 (+0.66)
Shares of PACB Up 42.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 02, 9:15AM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ ACB) on August 29th, 2014 at $5.80. In approximately 5 months, Pacific Biosciences of California has returned 42.54% as of today's recent price of $8.26.
PACB: 6.96 (-0.06)
ULTI, GBL, ENTR, PACB, MWA, QNST Expected To Be Down After Next Earnings Releases
M2 - Mon Feb 02, 2:51AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, February 3rd 2015 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and February earnings reports. Ultimate Software Group Inc (NASDAQ:ULTI), GAMCO Investors Inc (NYSE:GBL), Entropic Communications Inc (NASDAQ:ENTR), Pacific Biosciences of California Inc (NASDAQ ACB), Mueller Water Products Inc (NYSE:MWA), Quinstreet Inc (NASDAQ:QNST) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Tuesday:
PACB: 6.96 (-0.06), ULTI: 163.76 (+1.60), GBL: 79.47 (-1.00), MWA: 9.19 (+0.09), ENTR: 2.92 (unch), QNST: 6.15 (+0.07)
Shares of PACB Up 36.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jan 23, 4:43PM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ ACB) on August 29th, 2014 at $5.80. In approximately 5 months, Pacific Biosciences of California has returned 35.98% as of today's recent price of $7.88.
PACB: 6.96 (-0.06)
Pacific Biosciences Is Being Eaten Alive By Illumina
Doug Van Cuyk - at Seeking Alpha - Thu Feb 12, 7:59AM CST
PACB: 6.96 (-0.06), ILMN: 198.54 (+1.81)
Nasdaq stocks posting largest percentage decreases
AP - Thu Feb 05, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
SPLS: 16.86 (-0.22), PPSI: 9.09 (-0.26), ADXS: 7.18 (+0.06), GEOS: 19.15 (+0.02), MTRX: 19.92 (+0.77), AIRT: 19.45 (+0.39), PACB: 6.96 (-0.06), ADEP: 6.93 (-0.30), PRQR: 18.32 (-0.86), DERM: 16.52 (-0.11), LAYN: 7.93 (+0.22), ACHN: 10.89 (-0.20), POWL: 33.41 (+0.39), PLNR: 6.63 (-0.07), MFNC: 11.61 (+0.36)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 11:44AM CST
CALX: 8.65 (-0.03), NES: 3.52 (+0.13), RVP: 5.14 (-0.42), RL: 135.20 (-0.60), SR: 1.25 (+0.08), MWA: 9.19 (+0.09), OHGI: 1.82 (-0.12), GENE: 8.04 (+1.90), CALI: 1.35 (+0.06), WPRT: 6.06 (+0.26), RSYS: 2.15 (+0.05), EGLT: 10.60 (+0.58), PACB: 6.96 (-0.06), ACHN: 10.89 (-0.20), BBSI: 39.78 (+0.84), AVEO: 0.84 (-0.06), CBLI: 3.24 (+0.05), ENG: 1.85 (-0.06), PLNR: 6.63 (-0.07)
Why Shares of Pacific Biosciences of California Inc. Tanked Today
George Budwell, The Motley Fool - Motley Fool - Wed Feb 04, 11:29AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Shares of Pacific Biosciences of California plunged...
PACB: 6.96 (-0.06), FMI: 48.88 (+0.17)
Pac Bio down after earnings report
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 11:14AM CST
PACB: 6.96 (-0.06)
Pacific Biosciences Of California (PACB) Weak On High Volume Today
at The Street - Wed Feb 04, 9:03AM CST
Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a weak on high relative volume candidate
PACB: 6.96 (-0.06)
Pacific Bio ups revenues 115% in FY2014
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 8:53AM CST
PACB: 6.96 (-0.06)
Pacific Biosciences Posts Q4 Loss as Expected, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 8:28AM CST
Pacific Biosciences of California Inc. (PACB) plunged 5.2% (43 cents) to $7.90 in after-hours trading on the heels of disappointing fourth-quarter results.
ABMD: 60.39 (+0.46), PACB: 6.96 (-0.06), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Pacific Biosciences' Q4 2014 net loss widens to USD19.0m
M2 - Wed Feb 04, 5:24AM CST
DNA sequencing company Pacific Biosciences of California (NasdaqGS
ACB) on Tuesday disclosed a net loss of USD19.0m for the Q4 2014. PACB: 6.96 (-0.06)
Pacific Biosciences of California's (PACB) CEO Michael Hunkapiller on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 03, 9:04PM CST
PACB: 6.96 (-0.06)
Pacific Biosciences reports 4Q loss
Automated Insights - Tue Feb 03, 3:58PM CST
MENLO PARK, Calif. (AP) _ Pacific Biosciences of California Inc. (PACB) on Tuesday reported a loss of $19 million in its fourth quarter.
PACB: 6.96 (-0.06)
Pacific Biosciences of California (PACB) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Feb 03, 3:25PM CST
PACB: 6.96 (-0.06)
Pacific Biosciences Reports Fourth Quarter 2014 Financial Results
GlobeNewswire - Tue Feb 03, 3:18PM CST
Pacific Biosciences of California, Inc. (Nasdaq
ACB) today reported an 85% increase in revenue to $16.9 million for the fourth quarter ended December 31, 2014, compared to $9.1 million for the fourth quarter of 2013. PACB: 6.96 (-0.06)
Pacific Biosciences of California EPS in-line, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 3:03PM CST
PACB: 6.96 (-0.06)
Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 4:35PM CST
CALX: 8.65 (-0.03), CHRW: 72.58 (+0.75), WYNN: 159.34 (+4.62), SPA: 22.31 (-0.02), MANH: 51.61 (+0.89), OCLR: 1.55 (+0.09), RSYS: 2.15 (+0.05), NSR: 24.61 (+0.10), CENT: 9.00 (-0.08), CMG: 674.89 (+4.60), AJG: 47.50 (+0.27), IACI: 64.60 (+0.96), VASC: 26.44 (+0.79), SLGN: 56.85 (-0.08), UNM: 34.76 (+0.51), ATW: 33.75 (+0.63), ENTR: 2.92 (unch), AEC: 23.85 (-0.32), AXS: 51.86 (+0.02), MYGN: 34.03 (+0.40), LSCC: 6.10 (+0.02), RNR: 103.80 (-0.64), CBL: 20.52 (-0.14), ATO: 52.52 (-0.65), EW: 134.23 (+1.89), EXP: 81.57 (+2.41), DIS: 104.17 (+0.59), MWA: 9.19 (+0.09), QNST: 6.15 (+0.07), TTWO: 28.40 (+0.96), ULTI: 163.76 (+1.60), PACB: 6.96 (-0.06), FISV: 78.70 (+0.25), GILD: 101.90 (+1.10), JKHY: 65.78 (+0.52), RNG: 16.04 (unch), WNC: 14.01 (+0.38), OMCL: 35.29 (+0.03), AFL: 62.13 (+0.33), HCSG: 33.23 (-0.13), WRB: 50.27 (+0.08), PLNR: 6.63 (-0.07), EQR: 78.75 (-1.11)
Will Pacific Biosciences (PACB) Surprise on Earnings in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 3:40PM CST
Pacific Biosciences of California, Inc. (PACB) has an earnings ESP of 0.00% and is scheduled to report fourth-quarter 2014 results on Feb 3, 2015 after the market closes.
ACT: 285.37 (+3.71), PACB: 6.96 (-0.06), ARIA: 7.35 (+0.45), REGN: 402.40 (+0.66)
Shares of PACB Up 42.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 02, 9:15AM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ
ACB) on August 29th, 2014 at $5.80. In approximately 5 months, Pacific Biosciences of California has returned 42.54% as of today's recent price of $8.26. PACB: 6.96 (-0.06)
ULTI, GBL, ENTR, PACB, MWA, QNST Expected To Be Down After Next Earnings Releases
M2 - Mon Feb 02, 2:51AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, February 3rd 2015 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and February earnings reports. Ultimate Software Group Inc (NASDAQ:ULTI), GAMCO Investors Inc (NYSE:GBL), Entropic Communications Inc (NASDAQ:ENTR), Pacific Biosciences of California Inc (NASDAQ
ACB), Mueller Water Products Inc (NYSE:MWA), Quinstreet Inc (NASDAQ:QNST) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Tuesday: PACB: 6.96 (-0.06), ULTI: 163.76 (+1.60), GBL: 79.47 (-1.00), MWA: 9.19 (+0.09), ENTR: 2.92 (unch), QNST: 6.15 (+0.07)
Shares of PACB Up 36.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jan 23, 4:43PM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ
ACB) on August 29th, 2014 at $5.80. In approximately 5 months, Pacific Biosciences of California has returned 35.98% as of today's recent price of $7.88. PACB: 6.96 (-0.06)
